Elevance Health Inc
ELV
Market Cap$122.47B
Close$
Earnings Call Q4 2023
January 24, 2024 - AI Summary
Elevance Health reported strong fourth quarter and full-year 2023 earnings, exceeding expectations.
The company achieved its sixth consecutive year of growth in adjusted diluted earnings per share, with a compound annual growth rate exceeding the high end of the target range.
Carelon, the company's subsidiary, made significant progress in expanding capabilities and services, including the recent acquisition of Paragon Healthcare.
Exclusive for Stockcircle Pro members
Sign up
$1074.33
104.4% upside
Current Fair Value
104.4% upsideUndervalued by 104.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $122.47 Billion |
|---|---|
| Enterprise Value | $148.93 Billion |
| Dividend Yield | $6.0417 (1.15%) |
| Earnings per Share | $26.45 |
| Beta | 0.35 |
| Outstanding Shares | 232,417,867 |
| Avg 30 Day Volume | 1,121,395 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 19.61 |
|---|---|
| PEG | 151.8 |
| Price to Sales | 0.72 |
| Price to Book Ratio | 3.02 |
| Enterprise Value to Revenue | 0.87 |
| Enterprise Value to EBIT | 16.4 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.65 |
Revenue Sources
No data
ESG Score
No data
About Elevance Health Inc
83,400 employees
CEO: Gail Boudreaux Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million wit...